Literature DB >> 13367339

The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system.

H S GINSBERG, L PILLEMER, R J WEDGWOOD.   

Abstract

Detailed experiments are presented which indicate that the properdin system is an inhibitor of Newcastle disease virus. Viral inhibition required all known components of the properdin system: properdin, all four components of complement and magnesium; the removal of any one constituent resulted in a loss of inhibition; the replacement of the constituent restored antiviral effect. The inhibition of virus was temperature-dependent. The process of inhibition by serum resulted in a decrease in the amount of properdin available in the serum without any measurable effect on the components of complement. The prolonged incubation of inactive serum-virus mixtures with cation-exchange resin resulted in the restoration of some, but not all, of the hemagglutinating activity of the virus. The requirements of the properdin system and the implication of these findings were discussed.

Entities:  

Keywords:  IMMUNITY; NEWCASTLE DISEASE/virus; SERUM GLOBULIN

Mesh:

Substances:

Year:  1956        PMID: 13367339      PMCID: PMC2136619          DOI: 10.1084/jem.104.5.707

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  C F HINZ; W S JORDAN; L PILLEMER
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

2.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Poliomyelitis viruses in tissue culture. V. Reaction of virus and antibody; variables of the quantitative neutralization test.

Authors:  N LEDINKO; J L MELNICK
Journal:  Am J Hyg       Date:  1953-09

5.  The influence of certain serum factors on the neutralization of western equine encephalomyelitis virus.

Authors:  T F DOZOIS; J C WAGNER
Journal:  J Immunol       Date:  1949-07       Impact factor: 5.422

6.  The dengue group of viruses and its family relationships.

Authors:  A B SABIN
Journal:  Bacteriol Rev       Date:  1950-09

7.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

8.  The influence of calcium ions on the inactivation of human complement and its components by plasmin.

Authors:  I H LEPOW; L PILLEMER; O D RATNOFF
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

9.  A labile component of normal serum which combines with various viruses; neutralization of infectivity and inhibition of hemagglutination by the component.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

10.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

View more
  20 in total

1.  [SERUM PROPERDIN IN THE COURSE OF VIRUS DISEASES. DETERMINED ON AN EXAMPLE OF HEPATITIS].

Authors:  F SCHEIFFARTH; K D TYMPNER; W FRENGER
Journal:  Klin Wochenschr       Date:  1964-04-15

2.  [On the occurrence of a variant of type 25 ECHO virus].

Authors:  W HENIGST
Journal:  Arch Gesamte Virusforsch       Date:  1963 Spring-Fall

3.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

4.  Serum and tissue inhibitors of virus.

Authors:  H S GINSBERG
Journal:  Bacteriol Rev       Date:  1960-03

5.  [Methodical and clinical research on the properdin system. II. Research on the behavior of the serum properdin and the C'3 components after gynecological operations].

Authors:  G SCHUMACHER; E EL HABASH; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

6.  [Methodical and clinical research on the properdin system. I. Methodical research on the simplified properdin test according to Isliker].

Authors:  G SCHUMACHER; F KNIERIM; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

7.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11

8.  [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].

Authors:  K H HUSMANN
Journal:  Z Hyg Infektionskr       Date:  1959

Review 9.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

10.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.